SEC Form 4 · accession 0001437749-16-024795
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Borys
Officer — CMO
Period of report
Feb 2, 2016
Accepted (ET)
Feb 4, 2016 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000749647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Celsion Corporation Common StockF1,F2 | Feb 2, 2016 | A | 12,000 | $1.33 | A | 19,926 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Celsion Corporation Common StockF3,F4 | $1.33 | Feb 2, 2016 | A | 50,000 | A | Feb 2, 2016 | Feb 2, 2026 | Celsion Corporation Common Stock | 50,000 | 275,550 | D |
Explanation of responses
- F1The Filer was provided a fully vested stock grant on February 2, 2016.
- F2Represents the per share fair value of the common stock grant based on the closing price of Celsion Corporation Common Stock on the date of grant.
- F3Represents the closing price of Celsion Corporation Common Stock on the date of grant.
- F4The option vests in thirds on February 2, 2016, February 2, 2017 and February 2, 2018.